Immune Regulation

Developer of smal molecule based therapeutics for inflammatory and respiratory diseases

placeStevenage, England, United Kingdom calendar_todayFounded 2011 groups9 employees language immuneregulation.com

Innovation

5 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 43 times.

YearFilings
20182
20195
20203
20213
20221
20231
20241

Investor mix

3 investors on record.

Investor typeCountShare
Other / undisclosed3100%
Coming soon